Oncostatin M Gene Therapy Attenuates Liver Damage Induced by Dimethylnitrosamine in Rats
Tetsuhiro Hamada(Hyogo Medical University), Tohru Tsujimura(Hyogo Medical University), Ayuko Sato(Hyogo Medical University), Atsushi Miyajima(Meiji Pharmaceutical University), Takashi Yamamoto(Koga Hospital), Takashi Nishigami(Hyogo Medical University), Tadamichi Hirano(Hyogo Medical University), Minoru Tanaka(National Center for Global Health and Medicine), Shuhei Nishiguchi(Osaka City General Hospital), Masayuki Onodera(Hyogo Medical University), Jiro Fujimoto(Harvard University), Gakuhei Son(Hyogo Medical University), Ikuko Torii(Hyogo Medical University)
Cited by 37
Related Papers
A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.
|The EMBO Journal|1995|758
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
|Journal of Biological Chemistry|2004|583
Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis
|Cell Death and Disease|2019|501